News & Press

ATUM in the News
February 18, 2025
Developing stable cell lines is a complex, time-intensive process involving numerous steps.
July 9, 2024
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
February 22, 2024
Mitigating the aggregation challenge in immunocytokine production: Strategies during cell line development and purification optimization
February 6, 2024
Directed Evolution for Protein Engineering
January 10, 2024
Pharma Turns to New Tech for Biologics
January 4, 2024
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
Load More
Press Releases

ATUM Launches discoCHOâ„¢

Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases

ATUM Partners with Anagram Therapeutics to Extend Collaboration to Develop Orally Delivered Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders

ATUM Awarded EcoVadis Silver Medal Rating for its Sustainability Performance

Share

Search